Sandoz Changes Clozapine Marketing Strategy

OPEN MINDS The Behavioral Health & Social Service Industry Analyst Industry News Sandoz Pharmaceutical Corporation has agreed to stop requiring users to purchase blood monitoring services through CareMark Patient Monitoring System when purchasing clozapine. Without the required monitoring system the cost of clozapine will drop from $9,000 a year to $4,500 to $5,000 per year. Sandoz made its decision to alter its marketing practices in response to political and legal pressure from a coalition of government and mental health organizations. On December 18,1990, 23 states filed suit against the pharmaceutical company. Staff and board members of . . .